Taysha Gene Therapies, Inc. - Common Stock (TSHA)
1.5150
+0.0350 (2.36%)
Taysha Gene Therapies Inc is a biotechnology company focused on developing and delivering innovative gene therapies for the treatment of various neurological diseases, particularly genetic disorders that impact the central nervous system
By leveraging advanced technologies, Taysha aims to create transformative therapies that address the underlying causes of these diseases, providing hope for patients with limited treatment options. The company's research and development efforts emphasize collaboration with leading academic institutions and experts to advance its pipeline of gene therapy products toward clinical application.
Frequently Asked Questions
Is Taysha Gene Therapies, Inc. - Common Stock publicly traded?
Yes, Taysha Gene Therapies, Inc. - Common Stock is publicly traded.
What exchange does Taysha Gene Therapies, Inc. - Common Stock trade on?
Taysha Gene Therapies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Taysha Gene Therapies, Inc. - Common Stock?
The ticker symbol for Taysha Gene Therapies, Inc. - Common Stock is TSHA on the Nasdaq Stock Market
What is the current price of Taysha Gene Therapies, Inc. - Common Stock?
The current price of Taysha Gene Therapies, Inc. - Common Stock is 1.515
When was Taysha Gene Therapies, Inc. - Common Stock last traded?
The last trade of Taysha Gene Therapies, Inc. - Common Stock was at 1:36 pm EST on January 31st, 2025
What is the market capitalization of Taysha Gene Therapies, Inc. - Common Stock?
The market capitalization of Taysha Gene Therapies, Inc. - Common Stock is 97.66M
How many shares of Taysha Gene Therapies, Inc. - Common Stock are outstanding?
Taysha Gene Therapies, Inc. - Common Stock has 64.47M shares outstanding.